‡a
Author's Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
‡a
publishercorrectionclinicalefficacyandbiomarkeranalysisofneoadjuvantatezolizumabinoperableurothelialcarcinomaintheabacustrial
‡A
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
‡9
1
‡a
clinicalefficacyandbiomarkeranalysisofneoadjuvantatezolizumabinoperableurothelialcarcinomaintheabacustrial
‡A
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
‡9
1